Peregrine Pharmaceuticals reported $33.02M in Trade Debtors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Agenus AGEN:US USD 8.82M 10.17M
Amgen AMGN:US USD 5.33B 1000K
AstraZeneca AZN:LN USD 10.06B 449M
Biocryst Pharmaceuticals BCRX:US USD 42.61M 1.12M
Bristol Myers Squibb BMY:US USD 13.24B 700M
Celldex Therapeutics CLDX:US USD 189K 92K
Eli Lilly And LLY:US USD 8.32B 652.4M
GlaxoSmithKline GSK:LN GBP 8.09B 1.22B
Immunogen IMGN:US USD 4.19M 1.76M
Intrexon XON:US USD 2.45M 583K
Karyopharm Therapeutics KPTI:US USD 27.45M 3.97M
Macrogenics MGNX:US USD 13.84M 4.55M
Mannkind MNKD:US USD 23.49M 8.46M
Newlink Genetics NLNK:US USD 168K 19K
Novartis NOVN:VX USD 8.68B 230M
Novavax NVAX:US USD 111.64M 82.89M
Peregrine Pharmaceuticals PPHM:US USD 33.02M 7.11M
Repligen RGEN:US USD 117.64M 3.4M
Xencor XNCR:US USD 44.88M 9.41M